Resistome and virulome study on pathogenic Streptococcus agalactiae Guangzhou-SAG036

Microbial Pathogenesis - Tập 147 - Trang 104258 - 2020
Zhenbo Xu1,2,3,4, Zerong Lu1, Thanapop Soteyome4, Ling Chen1, Yi Liang5, Caiying Bai6, Tengyi Huang3, Junyan Liu7, Janette M. Harro8, Birthe V. Kjellerup7
1School of Food Science and Engineering, Guangdong Province Key Laboratory for Green Processing of Natural Products and Product Safety, South China University of Technology, Guangzhou, 510640, China
2Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38103, USA
3Department of Laboratory Medicine, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China
4Home Economics Technology, Rajamangala University of Technology Phra Nakhon, Bangkok, Thailand
5Guangdong Zhongqing Font Biochemical Science and Technology Co. Ltd., Maoming, Guangdong, 525427, China
6Guangdong Women and Children Hospital, Guangzhou, 510010, China
7Department of Civil and Environmental Engineering, University of Maryland, College Park, MD, 20742, USA
8Department of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, MD 21201, USA

Tài liệu tham khảo

Kwatra, 2016, Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis, Lancet Infect. Dis., 16, 1076, 10.1016/S1473-3099(16)30055-X Lin, 2003, Prematurity is the major risk factor for late‐onset group B Streptococcus disease, J. Infect. Dis., 188, 267, 10.1086/376457 Colbourn, 2007, An overview of the natural history of early onset group B streptococcal disease in the UK, Early Hum. Dev., 83, 149, 10.1016/j.earlhumdev.2007.01.004 Edmond, 2012, Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis, Lancet, 379, 547, 10.1016/S0140-6736(11)61651-6 Creti, 2017, Streptococcus infections: prevention strategies, clinical and microbiologic characteristics in 7 Years of surveillance, Pediatr. Infect. Dis. J., 36, 256, 10.1097/INF.0000000000001414 Schrag, 2013, Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine, Vaccine, 31, D20, 10.1016/j.vaccine.2012.11.056 Furfaro, 2018, Perinatal Streptococcus agalactiae epidemiology and surveillance targets, Clin. Microbiol. Rev., 31, 10.1128/CMR.00049-18 Maisey, 2008, Recent advances in understanding the molecular basis of group B Streptococcus virulence, Expet Rev. Mol. Med., 10, e27, 10.1017/S1462399408000811 Da Cunha, 2014, Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline, Nat. Commun., 5, 10.1038/ncomms5544 Bisharat, 2004, Hyperinvasive neonatal group B Streptococcus has arisen from a bovine ancestor, J. Clin. Microbiol., 42, 2161, 10.1128/JCM.42.5.2161-2167.2004 Chin, 2013, Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data, Nat. Methods, 10, 563, 10.1038/nmeth.2474 Tatusova, 2016, NCBI prokaryotic genome annotation pipeline, Nucleic Acids Res., 44, 6614, 10.1093/nar/gkw569 Lagesen, 2007, RNAmmer: consistent and rapid annotation of ribosomal RNA genes, Nucleic Acids Res., 35, 3100, 10.1093/nar/gkm160 Lowe, 2016, tRNAscan-SE On-line: integrating search and context for analysis of transfer RNA genes, Nucleic Acids Res., 44, W54, 10.1093/nar/gkw413 Nawrocki, 2013, Infernal 1.1: 100-fold faster RNA homology searches, Bioinformatics, 29, 2933, 10.1093/bioinformatics/btt509 Tarailo-Graovac, 2009, Using RepeatMasker to identify repetitive elements in genomic sequences, Curr. Protoc. Bioinformatics., 10.1002/0471250953.bi0410s25 Larsen, 2012, Multilocus sequence typing of total-genome-sequenced bacteria, J. Clin. Microbiol., 50, 1355, 10.1128/JCM.06094-11 Finn, 2014, Pfam: the protein families database, Nucleic Acids Res., 42, D222, 10.1093/nar/gkt1223 Krogh, 2001, Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes, J. Mol. Biol., 305, 567, 10.1006/jmbi.2000.4315 Stebbins, 2009, Sequence-based prediction of type III secreted proteins, PLoS Pathog., 5 Petersen, 2011, SignalP 4.0: discriminating signal peptides from transmembrane regions, Nat. Methods, 8, 785, 10.1038/nmeth.1701 Zankari, 2012, Identification of acquired antimicrobial resistance genes, J. Antimicrob. Chemother., 67, 2640, 10.1093/jac/dks261 Kao, 2019, Emerging serotype III sequence type 17 group B streptococcus invasive infection in infants: the clinical characteristics and impacts on outcomes, BMC Infect. Dis., 19, 10.1186/s12879-019-4177-y Lamy, 2006, Rapid detection of the "highly virulent" group B Streptococcus ST-17 clone, Microb. Infect., 8, 1714, 10.1016/j.micinf.2006.02.008 Rosenau, 2007, Evaluation of the ability of Streptococcus agalactiae strains isolated from genital and neonatal specimens to bind to human fibrinogen and correlation with characteristics of the fbsA and fbsB genes, Infect. Immun., 75, 1310, 10.1128/IAI.00996-06 Tenenbaum, 2007, Streptococcus agalactiae invasion of human brain microvascular endothelial cells is promoted by the laminin-binding protein Lmb, Microb. Infect., 9, 714, 10.1016/j.micinf.2007.02.015 Marques, 1992, Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci, Infect. Immun., 60, 3986, 10.1128/IAI.60.10.3986-3993.1992 Lewis, 2007, NeuA sialic acid O-acetylesterase activity modulates O-acetylation of capsular polysaccharide in group B Streptococcus, J. Biol. Chem., 282, 27562, 10.1074/jbc.M700340200 Bohnsack, 1991, Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus, Biochem. J., 273, 635, 10.1042/bj2730635 Ring, 2000, Group B streptococcal beta-hemolysin induces nitric oxide production in murine macrophages, J. Infect. Dis., 182, 150, 10.1086/315681 Doran, 2002, Group B streptococcal beta-hemolysin/cytolysin promotes invasion of human lung epithelial cells and the release of interleukin-8, J. Infect. Dis., 185, 196, 10.1086/338475 Lang, 2003, Characterization of Streptococcus agalactiae CAMP factor as a pore-forming toxin, J. Biol. Chem., 278, 38167, 10.1074/jbc.M303544200 Mello, 2002, Structure and flexibility of Streptococcus agalactiae hyaluronate lyase complex with its substrate. Insights into the mechanism of processive degradation of hyaluronan, J. Biol. Chem., 277, 36678, 10.1074/jbc.M205140200 Baron, 2004, Alpha C protein of group B Streptococcus binds host cell surface glycosaminoglycan and enters cells by an actin-dependent mechanism, J. Biol. Chem., 279, 24714, 10.1074/jbc.M402164200 Ambrose, 2005, Macrolide efflux in Streptococcus pneumoniae is mediated by a dual efflux pump (mel and mef) and is erythromycin inducible, Antimicrob. Agents Chemother., 49, 4203, 10.1128/AAC.49.10.4203-4209.2005 Ramirez, 2010, Aminoglycoside modifying enzymes, Drug Resist. Updates, 13, 151, 10.1016/j.drup.2010.08.003 Trieu-Cuot, 1983, Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3'5''-aminoglycoside phosphotransferase type III, Gene, 23, 331, 10.1016/0378-1119(83)90022-7 Cerda, 2007, Detection of the aminoglycosidestreptothricin resistance gene cluster ant(6)-sat4-aph(3 ')-III in commensal viridans group streptococci, Int. Microbiol., 10, 57 Clancy, 1997, Cloning and characterization of a novel macrolide efflux gene, mreA, from Streptococcus agalactiae, Antimicrob. Agents Chemother., 41, 2719, 10.1128/AAC.41.12.2719 Cheung, 2009, The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion, PLoS Pathog., 5 Roberts, 1996, Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution, FEMS Microbiol. Rev., 19, 1, 10.1111/j.1574-6976.1996.tb00251.x Yu, 1997, Solution structure of an rRNA methyltransferase (ErmAM) that confers macrolide-lincosamide-streptogramin antibiotic resistance, Nat. Struct. Biol., 4, 483, 10.1038/nsb0697-483 Min, 2008, Translational attenuation and mRNA stabilization as mechanisms of erm(B) induction by erythromycin, Antimicrob. Agents Chemother., 52, 1782, 10.1128/AAC.01376-07